BLCO
Bausch + Lomb Corporation
NYSE · Healthcare · Medical - Instruments & Supplies · CA
$18.07
−0.39%Year over year
Reported trailing growth
- Revenue
- +8.8%
- EBITDA
- +61.3%
- EBIT
- +375.0%
- EPS
- +38.5%
- Free cash flow
- +185.0%
- Operating cash flow
- +146.4%
Forward estimates
Based on analyst estimates
- Revenue
- +6.2%
- EBITDA
- +71.4%
- EPS
- +307.7%
Three-year CAGR
- Revenue
- +10.6%
- EBITDA
- -3.6%
- EBIT
- -3.2%
- Net income
- -13.6%
- EPS
- -13.3%
- Free cash flow
- -11.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026